Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 1, 2007, Pages 148-157

  Hisaoka, Kazue ^a   Takebayashi, Minoru ^a,c   Tsuchioka, Mami ^a,b   Maeda, Natsuko ^a   Nakata, Yoshihiro ^b   Yamawaki, Shigeto ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DIAZEPAM; DIPHENHYDRAMINE; DOPAMINE; FLUOXETINE; FLUVOXAMINE; GENISTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HALOPERIDOL; KETANSERIN; LITHIUM; MESSENGER RNA; MIANSERIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOAMINE; NORADRENALIN; NORTRIPTYLINE; PROTEIN TYROSINE KINASE; SEROTONIN; STRESS ACTIVATED PROTEIN KINASE; TRIHEXYPHENIDYL;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SPECIFICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIA CELL; HUMAN; HUMAN CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOGENIC MONOAMINES; BLOTTING, WESTERN; CELL LINE; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; L-LACTATE DEHYDROGENASE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN;

EID: 33947357645     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.116558     Document Type: Article

References (38)

1. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, and Eriksson PS (2000) Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896-2903.
2. Airaksinen MS and Saarma M (2002) The GDNF family: signaling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
3. Baldessarini RJ (2001) Drugs and the treatment of psychiatric disorders: depression and anxiety disorders, in Goodman & Gilman' The Pharmacological Basis of Therapeutics (Hardman JG, Limbird LE, and Gilman AG eds) 10th ed, pp 447-483, McGraw-Hill Book Companies, New York.
4. Baumann P, Gaillard JM, Jonzier-Perey M, Gerber C, and Bouras C (1984) Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology 84:489-495.
5. Belcheva MM, Haas PD, Tan Y, Heaton VM, and Coscia CJ (2002) The fibroblast growth factor receptor is at the site of convergence between μ-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J Pharmacol Exp Ther 303:909-918.
6. Burke MJ and Preskorn SH (1995) Short-term treatment of mood disorders with standard antidepressants, in Psychopharmacology (Bloom FE and Kupfer DJ eds) 4th ed, pp 1053-1065, Raven Press Ltd., New York.
7. Chen Y, Ai Y, Slevin JR, Maley BE, and Gash DM (2005) Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp Neurol 196:87-95.
8. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. 5:11-25.
9. Elliott JM, Newberry NR, Cholewinski AJ, Bartrup JT, Briddon SJ, Carey JE, Flanigan TP, Newton RA, Phipps SL, Reavley AC, et al. (1995) Characterization of the 5-hydoxytryptamine2A receptor-activated cascade in rat C6 glioma cells. Neuroscience 69:1119-1131.
10. Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, Lopez JF, Thompson RC, Meng F, Stead JD, et al. (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101:15506-15511.
11. Gerlai R, McNamara A, Choi-Lundberg DL, Armanini M, Ross J, Powell-Braxton L, and Phillips HS (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur J Neurosci 14:1153-1163.
12. Glotzbach RK and Preskorn SH (1982) Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology 78:25-27.
13. Hisaoka K, Nishida A, Koda T, Miyata M, Zensho H, Morinobu S, Ohta M, and Yamawaki S (2001) Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 79:25-34.
14. Hisaoka K, Nishida A, Takebayashi M, Koda T, Yamawaki S, and Nakata Y (2004) Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res 1002:167-170.
15. Hock C, Heese K, Muller-Spahn F, Huber P, Riesen W, Nitsch RM, and Otten U (2000) Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 5:510-513.
16. Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, Logvinova A, and Greenberg DA (2003) Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2:175-183.
17. Kawanabe Y, Hashimoto N, and Masaki T (2003) Effects of nonselective cation channels and PI3K on endothelin-1-induced PYK2 tyrosine phosphorylation in C6 glioma cells. Am J Physiol 285:C539-C545.
18. Kelleher RJ, Govindarajan A, Jung H-Y, Kang H, and Tonegawa S (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116:467-479.
19. Lazar J, Szabo T, Marincsak R, Kovacs L, Blumberg PM, and Biro T (2004) Sensitization of recombinant vanilloid receptor-1 by various neurotrophic factors. Life Sci 75:153-163.
20. Lee R, Kermani P, Teng KK, and Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science (Wash DC) 294:1945-1948.
21. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) method. Methods 25:402-408.
22. Malberg JE and Schechter LE (2005) Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des 11:145-155.
23. Manji HK, Drevets WC, and Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541-547.
24. Messer CJ, Eisch AJ, Carlezon WA Jr, Whisler K, Shen L, Wolf DH, Westphal H, Collins F, Russell DS, and Nestler EJ (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26:247-257.
25. Miyake K, Fukuchi H, Kitaura T, Kimura M, Sarai K, and Nakahara T (1990) Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J Pharm Sci 79:288-291.
26. 2+ mobilization in C6 glioma cells through a calmodulin-dependent pathway. J Neurochem 71:1709-1718.
27. Newton SS and Duman RS (2004) Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res 1:261-267.
28. Öngür D, Drevets WC, and Price JL. (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95:13290-13295.
29. Prouty RW and Anderson WH (1990) The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 35:243-270.
30. Rajkowska G (2002) Cell pathology in mood disorders. Semin Clin Neuropsychiatry 7:281-292.
31. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (Wash DC) 301:805-809.
32. Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, and Croll S (2005) Increased neurogenesis and the ectopic granule cells after intra hippocampal BDNF infusion in adult rats. Exp Neurol 192:348-356.
33. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75.
34. Shinagawa S (1994) Serotonin protects C6 glioma cells from glutamate toxicity. Neuroscience 59:1043-1050.
35. Takebayashi M, Hisaoka K, Nishida A, Tsuchioka M, Miyoshi I, Kozuru T, Hikasa S, Okamoto Y, Shinno H, Morinobu S, et al. (2006) Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol 9:607-612.
36. Tsuchioka M, Takebayashi M, Hisaoka K, Shinno H, and Nakata Y (2005) Serotonin (5-HT) induced glial cell line-derived neurotrophic factor (GDNF) expression is mediated by transactivation of fibroblast growth factor receptor (FGFR) in rat C6 glioma cells, in Proceedings of the Society for Neuroscience 35th Annual Meeting; 2005 Nov 12-16; Washington, DC. Program no. 841.7. Society for Neuroscience, Washington, DC.
37. Tsuda T, Kusui T, and Jensen RT (1997) Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton. Biochemistry 36:16328-16337.
38. Zumwalt JW, Thunstrom BJ, and Spangelo BL (1999) Interleukin-1β and catecholamines synergistically stimulate interleukin-6 release from rat C6 glioma cells in vitro: a potential role for lysophosphatidylcholine. Endocrinology 140:888-896.